
FOLLOWUS
1. Mental Health Institute, Beijing Medical University,Beijing
2. Longquanshan Hospital,Guangxi
3. Ankang Hospital,Beijing
4. Minkang Hospital,Beijing
Published:1997,
Scan for full text
Luo, Hc., Shen, Yc., Yu, X. et al. Clinical study on Shuxuening combined with antipsychotics in treating chronic schizophreniacombined with antipsychotics in treating chronic schizophrenia., CJIM 3, 191–194 (1997). https://doi.org/10.1007/BF02935137
He-chun Luo, Yu-cun Shen, Xin Yu, et al. Clinical study on Shuxuening combined with antipsychotics in treating chronic schizophreniacombined with antipsychotics in treating chronic schizophrenia. [J]. Chinese Journal of Integrative Medicine 3(3):191-194(1997)
Luo, Hc., Shen, Yc., Yu, X. et al. Clinical study on Shuxuening combined with antipsychotics in treating chronic schizophreniacombined with antipsychotics in treating chronic schizophrenia., CJIM 3, 191–194 (1997). https://doi.org/10.1007/BF02935137 DOI:
He-chun Luo, Yu-cun Shen, Xin Yu, et al. Clinical study on Shuxuening combined with antipsychotics in treating chronic schizophreniacombined with antipsychotics in treating chronic schizophrenia. [J]. Chinese Journal of Integrative Medicine 3(3):191-194(1997) DOI: 10.1007/BF02935137.
Objective: To make a preliminary evaluation of the clinical efficacy of Shuxuening (SXN).Methods: One hundred and forty-nine chronic schizophrenic patients were divided randomly into the SXN group and the control group in a double-blind research. SXN was given to the SXN group and placebo to the control group
and patients of both groups went on receiving the previous antipsychotic treatment. Brief Psychiatric Rating Scale (BPRS)
Scale for Assessment of Negative Symptoms (SANS) and Treatment Emergent Symptoms Scale (TESS) were used to assess the effects of treatment and side effects of the drug. The evaluation was done before and during the 2nd
4th
6th
10th and 12 th weeks in the course of treatment.Results: SXN was effective by BPRS evaluation (P < 0.05)
and even the more effective to negative symptoms than positive symptoms by SANS evaluation (P < 0.05). It was safe and with little side effect. In addition
it was found that the incipience of SXN’ s efficacy was somehow related with the course of disease and the daily dosage used.Conclusion: SXN is worthy of further study n the treatment of chronic schizophrenia.
Objective: To make a preliminary evaluation of the clinical efficacy of Shuxuening (SXN).Methods: One hundred and forty-nine chronic schizophrenic patients were divided randomly into the SXN group and the control group in a double-blind research. SXN was given to the SXN group and placebo to the control group
and patients of both groups went on receiving the previous antipsychotic treatment. Brief Psychiatric Rating Scale (BPRS)
Scale for Assessment of Negative Symptoms (SANS) and Treatment Emergent Symptoms Scale (TESS) were used to assess the effects of treatment and side effects of the drug. The evaluation was done before and during the 2nd
4th
6th
10th and 12 th weeks in the course of treatment.Results: SXN was effective by BPRS evaluation (P < 0.05)
and even the more effective to negative symptoms than positive symptoms by SANS evaluation (P < 0.05). It was safe and with little side effect. In addition
it was found that the incipience of SXN’ s efficacy was somehow related with the course of disease and the daily dosage used.Conclusion: SXN is worthy of further study n the treatment of chronic schizophrenia.
chronic schizophreniaflavonesShuxuening
chronic schizophreniaflavonesShuxuening
3 1994; 597–598.
1991, 10: 331.
Defeudis FV. Ginkgo biloba extract (EGb 761):Pharmacological activities and clnical applications. Paris Elcevier, 1991.
Pacher L, Prilipko L, Christer Y. Free radical in the brain: aging, neurological and mental disorders. Berlin Springer-Verlag, 1992.
Prilipko L. Free radicals in the brain: aging, neurological and mental disorders. Berlin Springer-Verlag, 1992.
LPO SOD 994: 49–50.
1989: 530.
Hans-Peter VJ, Rudolf H. 1995: (1): 2.
I. II 1992, 25: 68.
1994, 27: 6.
0
Views
326
Downloads
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621